Kalexsyn Overview
- Year Founded
-
2003
- Status
-
Acquired/Merged
- Employees
-
32
- Latest Deal Type
-
M&A
Kalexsyn General Information
Description
Provider of medicinal chemistry services designed to support drug discovery programs at pharmaceutical and biotech companies. The company provide hypothesis-driven medicinal chemistry and also offers services to solve complex synthetic problems and deliver complex molecular targets. It provides unique expertise to provide hypothesis-driven medicinal chemistry and excellent ROI through our efficiency and productivity in meeting our customers' goals. It offers an outstanding CRO experience with fixed quote as well as short and long-term FTE arrangements.
Contact Information
Website
www.kalexsyn.comCorporate Office
- 4502 Campus Drive
- Kalamazoo, MI 49008
- United States
Corporate Office
- 4502 Campus Drive
- Kalamazoo, MI 49008
- United States
Kalexsyn Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 17-May-2018 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 05-Nov-2007 | Completed | Startup | |||
| 1. Accelerator/Incubator | 01-Jan-2003 | Completed | Startup |
Kalexsyn Comparisons
Industry
Financing
Details
Kalexsyn Competitors (10)
One of Kalexsyn’s 10 competitors is Parexel International, a Private Equity-Backed company based in Raleigh, NC.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Parexel International | Private Equity-Backed | Raleigh, NC | ||||
| Rho | Corporation | Durham, NC | ||||
| Adesis | Corporate Backed or Acquired | New Castle, DE | ||||
| Charles River Laboratories International | Formerly PE-Backed | Wilmington, MA | ||||
| Syneos Health | Private Equity-Backed | Morrisville, NC |
Kalexsyn Patents
Kalexsyn Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20230111914-A1 | Synthetic triterpenoids with nitrogen-based substituents at c-17 and methods of use thereof | Active | 19-Dec-2019 | ||
| US-11629150-B2 | Synthesis of n-(heteroaryl)-pyrrolo[3,2-d]pyrimidin-2-amines | Active | 01-Jul-2016 | ||
| US-20210122755-A1 | Synthesis of n-(heteroaryl)-pyrrolo[3,2-d]pyrimidin-2-amines | Active | 01-Jul-2016 | ||
| US-20150297608-A1 | Tricyclic lactams for use as anti-neoplastic and anti-proliferative agents | Inactive | 17-Apr-2014 | ||
| US-10376519-B2 | Tricyclic lactams for use in hspc-sparing treatments for rb-positive abnormal cellular proliferation | Active | 17-Apr-2014 | A61K31/5377 |
Kalexsyn Signals
Kalexsyn Former Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Biosciences Research and Commercialization Center | Venture Capital | Minority | ||
| Southwest Michigan Innovation Center | Accelerator/Incubator |
Kalexsyn FAQs
-
When was Kalexsyn founded?
Kalexsyn was founded in 2003.
-
Where is Kalexsyn headquartered?
Kalexsyn is headquartered in Kalamazoo, MI.
-
What is the size of Kalexsyn?
Kalexsyn has 32 total employees.
-
What industry is Kalexsyn in?
Kalexsyn’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Kalexsyn a private or public company?
Kalexsyn is a Private company.
-
What is Kalexsyn’s current revenue?
The current revenue for Kalexsyn is .
-
How much funding has Kalexsyn raised over time?
Kalexsyn has raised $225K.
-
Who are Kalexsyn’s investors?
Biosciences Research and Commercialization Center and Southwest Michigan Innovation Center have invested in Kalexsyn.
-
Who are Kalexsyn’s competitors?
Parexel International, Rho, Adesis, Charles River Laboratories International, and Syneos Health are some of the 10 competitors of Kalexsyn.
-
When was Kalexsyn acquired?
Kalexsyn was acquired on 17-May-2018.
-
Who acquired Kalexsyn?
Kalexsyn was acquired by Dipharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process